These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 3218970)
1. Terminal differentiation of human leukemic blasts in response to 12-0-tetradecanoyl-13-phorbol acetate (TPA). Joshi KS; Rao SG; Joshi DS; Advani SH; Bhisey AN Anticancer Res; 1988; 8(6):1367-71. PubMed ID: 3218970 [TBL] [Abstract][Full Text] [Related]
2. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission. Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922 [TBL] [Abstract][Full Text] [Related]
3. Study of differentiation of fresh human leukemic cells by low dose cytosine arabinoside (LD Ara-C) and 12-O-tetradecanoylphorbol-13-acetate (TPA). Kuliczkowski K; Noworolska A; Frydecka I; Sedek K; Harłozińska A Neoplasma; 1989; 36(5):589-97. PubMed ID: 2812152 [TBL] [Abstract][Full Text] [Related]
4. Heterogenous response of primary cultured bone marrow cells of patients with different varieties of leukemia to differentiation inducers. Chen ZX; Wang W; Wu WL Chin Med J (Engl); 1989 Mar; 102(3):174-82. PubMed ID: 2503303 [TBL] [Abstract][Full Text] [Related]
5. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia. Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971 [TBL] [Abstract][Full Text] [Related]
6. Phorbol ester-induced differentiation of a non-T/non-B human leukemic cell line (REH) to macrophage-like cells. Srivastava BI; Koga M; Srivastava P Cancer Res; 1984 Jul; 44(7):3017-21. PubMed ID: 6373000 [TBL] [Abstract][Full Text] [Related]
7. Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation. Koeffler HP; Bar-Eli M; Territo MC Cancer Res; 1981 Mar; 41(3):919-26. PubMed ID: 6936077 [TBL] [Abstract][Full Text] [Related]
8. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma. Munker R; Andreeff M Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699 [TBL] [Abstract][Full Text] [Related]
9. TPA induces differentiation of purified human myeloblasts in the absence of proliferation. Griffin JD; Larcom P; Kufe DW Exp Hematol; 1985 Nov; 13(10):1025-32. PubMed ID: 3932087 [TBL] [Abstract][Full Text] [Related]
10. [Retinoic acid and 12-0-tetradecanoylphorbol-13-acetate (TPA) inducing bipotent differentiation of cultured primary bone marrow cells from leukemia patients]. Chen ZX; Wu WL Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):26-9. PubMed ID: 1889336 [TBL] [Abstract][Full Text] [Related]
11. Multiplication of human fetal myelomonocytic precursors in medium conditioned by acute myelocytic leukemia cells treated by 12-O-tetradecanoyl phorbol 13-acetate (TPA). Svet-Moldavsky IA; Den T; Bowers CH; Wroblesky H Biomed Pharmacother; 1985; 39(9-10):472-7. PubMed ID: 3869046 [TBL] [Abstract][Full Text] [Related]
12. Differentiation of human leukemias in response to 12-0-tetradecanoylphorbol-13-acetate in vitro. Pegoraro L; Abrahm J; Cooper RA; Levis A; Lange B; Meo P; Rovera G Blood; 1980 May; 55(5):859-62. PubMed ID: 6928789 [TBL] [Abstract][Full Text] [Related]
13. Induction of human malignant T-lymphoblastic cell lines MOLT-3 and jurkat by 12-O-tetradecanoylphorbol-13-acetate: biochemical, physical, and morphological characterization. Nagasawa K; Howatson A; Mak TW J Cell Physiol; 1981 Oct; 109(1):181-92. PubMed ID: 6976970 [TBL] [Abstract][Full Text] [Related]
14. Effects of 12-O-tetradecanoylphorbol-13-acetate on the proliferation and differentiation of normal and leukemic myeloid progenitor cells. Ozawa K; Miura Y; Hashimoto Y; Kimura Y; Urabe A; Takaku F Cancer Res; 1983 May; 43(5):2306-10. PubMed ID: 6831455 [TBL] [Abstract][Full Text] [Related]
16. Phorbol ester induces differentiation of a human prostatic cancer cell line TSU-Pr1 into cells with characteristics of microglia. Itayasu T; Shimizu T; Iizumi T; Oshio S; Umeda T; Takeda K Anticancer Res; 1998; 18(1A):113-7. PubMed ID: 9568064 [TBL] [Abstract][Full Text] [Related]
17. Initiator and promoter induced specific changes in epidermal function and biological potential. Yuspa SH; Hennings H; Lichti U J Supramol Struct Cell Biochem; 1981; 17(3):245-57. PubMed ID: 7328673 [TBL] [Abstract][Full Text] [Related]
18. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies. Stöckbauer P; Malasková V; Soucek J; Chudomel V Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116 [TBL] [Abstract][Full Text] [Related]
19. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate. Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856 [TBL] [Abstract][Full Text] [Related]
20. Macrophage-like cell transformation and CFU(c) fluctuations in normal and leukemic human marrow cultures treated by phorbol diester. Svet-Moldavskaya IA; Zinzar SN; Svet-Moldavsky GJ; Mann PE; Bekesi JG; Holland JF; Clarkson BD; Arlin Z; Koziner B Biomedicine; 1979 Dec; 31(9-10):252-7. PubMed ID: 295676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]